A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study

NCT00330798 Phase 4 COMPLETED

The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.

Details

Lead sponsor	Alcon Research
Phase	Phase 4
Status	COMPLETED
Enrolment	40
Start date	2006-02
Completion	2006-06

Conditions

• Photorefractive Keratectomy

Interventions

• nepafenac 0.1%
• ketorolac 0.4%

Primary outcomes

• Subjective pain — Day 5

Countries

United States